Page 1359 - Small Animal Internal Medicine, 6th Edition
P. 1359

CHAPTER 81   Selected Neoplasms in Dogs and Cats   1331


              Buffy coat smears to search for circulating mast cells   As a general rule, in dogs with solitary MCTs in a location
            are not clinically useful. Interestingly, circulating mast cells   amenable to wide surgical excision and no negative prognos-
  VetBooks.ir  are more common in dogs with diseases other than MCTs;   tic indicators, routine staging diagnostics (with the excep-
                                                                 tion of regional lymph node aspiration) are not considered
            most dogs with mastocythemia have inflammatory disor-
            ders, regenerative anemia, tumors other than MCTs, or
                                                                 indication of “aggressive” histopathology (i.e., high grade)
            trauma. Circulating mast cells can frequently be recognized   mandatory and can be performed postoperatively if there is
            in the graphics of flow cytometry-based hematology ana-  (Table 81.1).
            lyzers (Fig. 81.8). Cytologic evaluation of a bone marrow
            aspirate may therefore be more beneficial for staging pur-  Treatment and Prognosis
            poses, when deemed appropriate. On the basis of all these   As discussed previously, it is imperative to know whether the
            facts, the appropriate staging procedures in dogs with MCTs   mass the clinician is preparing to excise is a MCT before
            remain controversial. The authors do not use buffy coat   surgery, because this information is useful when discussing
            smears or bone marrow aspirates routinely in dogs with   treatment options with the family and when planning the
            MCT and a normal CBC; if cytopenias or leukoerythro-  treatment strategy. Dogs with MCT can be treated with
            blastic reactions are present, a bone marrow aspirate may     surgery, radiotherapy, chemotherapy, molecular-targeted
            be performed.                                        therapy, or a combination of these. However, the first two



























                   A                                                B



















                                   C
                          FIG 81.8
                          Leukocyte dotplots in a dog with systemic mast cell disease and mastocythemia (A). Note
                          the second “peak” (blue circle) that represents the circulating mast cells, located to the
                          right of the normal cells (the horizontal axis depicts granularity, so cells with inclusions are
                          further to the right). (B) This image depicts a normal leukocyte graphic. (C) This image
                          shows a circulating poorly granulated mast cell (Diff-Quick stain, ×1000). Color code:
                          Purple, neutrophils; green, eosinophils; light blue, basophils; blue, lymphocytes; red,
                          monocytes; orange, unlysed red blood cells.
   1354   1355   1356   1357   1358   1359   1360   1361   1362   1363   1364